lthough young adults are a relatively small proportion of those having acute myocardial infarction (AMI), they are an important group to examine with regard to risk factor modification and secondary prevention. Previous studies have indicated that patients less than 40 years old comprise between 2% and 6% of all AMIs 1-3 and that AMI in young patients has different characteristics from that in older patients. Young AMI patients are characterized by a relatively high incidence of normal coronary arteries, non-obstructive stenosis, or single-vessel disease, 1,4,5 and high prevalence of current smoking, hyperlipidemia, and family history. 6, 7 In addition, non-classical risk factors, such as vasospastic tendency, thrombophilic conditions, and past history of Kawasaki disease, have also been proposed as the cause of AMI in young patients. [8] [9] [10] [11] [12] Recently we demonstrated that young Japanese patients with AMI are usually male and have a high prevalence of cigarette smoking, hypercholesterolemia, and family history, a higher frequency of single-vessel disease, and a lower frequency of left circumflex coronary artery as the culprit lesion. 13 As to the short-and long-term prognosis, most previous reports have shown a favorable prognosis after discharge in young AMI patients, 1,14,15 and we have already shown that initial results of primary percutaneous coronary intervention (PCI) and in-hospital outcome in young patients with AMI are comparable to those in non-young patients with AMI in Japan. 13 However, the data on the medium-and long-term prognosis of young Japanese patients with AMI, aged <40 years, are still lacking. The AMI-Kyoto MultiCenter Risk Study, a large multicenter observational study in which 15 collaborating hospitals in Kyoto Prefecture have collected demographic, procedural, and outcome data on AMI patients, was established in 2000 in order to analyze these data and establish an emergency-hospital network for heart disease in Kyoto. The purpose of the present study is therefore to examine retrospectively the medium-term outcome in young adults with AMI in Japan.
tive patients with a diagnosis of AMI, who were admitted to the AMI-Kyoto Multi-Center Risk Study Group Hospitals within 1 week after the onset of AMI, were enrolled in the present study. Of these, 25 patients who were less than 40 years old at the time of infarction were assigned to the young group. In an attempt to exclude as far as possible the influence of increased age on the medium-term outcome, we selected 287 patients aged 60-70 years at the time of infarction as the non-young group. Overall, all of the young patients (100%) and 269 of the non-young patients (93.7%) were free of in-hospital death. Follow-up data after discharge were obtained for 21 of the young patients (84.0%) (young group) and 190 of the non-young patients (70.6%) (non-young group). We retrospectively compared the clinical background, coronary risk factors, angiographic findings, acute results of primary PCI, and medium-term prognosis in both groups. The diagnosis of AMI required the presence of 2 of the following 3 criteria: (1) characteristic clinical history, (2) serial changes on the ECG suggesting infarction (Q-waves) or injury (ST-segment elevations), and (3) transient increase in cardiac enzymes to more than 2-fold the normal laboratory value.
Data Collection
The patients' demographic information, cardiovascular history, and risk factors (ie, smoking, hypercholesterolemia, hypertension, and diabetes mellitus) were recorded. Hypercholesterolemia was defined as total cholesterol ≥220 mg/dl or the use of cholesterol-lowering agents; hypertension was defined as systemic blood pressure ≥140/90 mmHg or a history of previous treatment; diabetes mellitus was defined as fasting blood sugar ≥120 mg/dl or the use of specific treatment. After informed consent to participate in the AMI-Kyoto Multi-Center Risk Study was given by each patient, all in-hospital data were transmitted to the center located at the Department of Cardiology and Vascular Regenerative Medicine in Kyoto Prefectural University School of Medicine for analysis. The study protocol was approved by each hospital's ethics committee.
Emergency Coronary Arteriography and Reperfusion Therapy
Emergency coronary angiography (CAG) was performed using the standard technique. The coronary flow in the infarct-related artery was graded according to the classification used in the Thrombolysis In Myocardial Infarction (TIMI) trial. Significant coronary artery stenosis was defined as at least 75% reduction in the internal diameter of the right, left anterior descending, or left circumflex coronary artery and the major branches, or 50% reduction in the internal diameter of the left main trunk. Non-significant stenosis was defined as coronary arterial narrowing less than significant stenosis. Patients with either angiographically normal coronary arteries or non-significant stenosis were classified as having zero-vessel disease. After the culprit lesions were ascertained by CAG, PCI was subsequently performed. Successful reperfusion was defined as the establishment of TIMI grade 3 flow in the infarctrelated artery on the final CAG. Left ventriculography was performed at the time of follow-up CAG before discharge.
Follow-up
Follow-up data were obtained from hospital records or by interviewing (directly or by telephone) patients, their families, or their personal physicians as of January 31, 2005 . Major adverse cardiac events (MACE) were defined as death, recurrent of AMI, percutaneous or surgical revascularization, and hospitalization for acute coronary syndrome heart failure, or arrhythmia. Each death was categorized as cardiac or non-cardiac: heart failure and arrhythmia were included in cardiac death, whereas death attributed to cerebral vascular disease, pneumonia, decrepitude etc was defined as non-cardiac.
Statistical Analysis
Data are expressed as mean ± SD. The young and nonyoung groups were compared using the chi-square test and unpaired Student's t-test according to standard statistical methods using a computer-based program. Survival and event-free survival curves were displayed using the KaplanMeier method, and differences were compared using logrank test. Correlates of MACE during the follow-up period were determined by Cox model analysis. In all analyses, significance was accepted at p<0.05.
Results

Patient Characteristics and Risk Factors
The clinical characteristics and risk factors in the 2 groups are summarized in all male and they had a significantly higher prevalence of smoking. In contrast, hypertension and previous myocardial infarction (MI) were more frequent in the non-young group. The body mass index (BMI) of the young group was significantly higher than that of the non-young group.
Elapsed time and Killip grade ≥3 at admission did not differ between the 2 groups.
Angiographic Data
Emergency CAG was performed in 20 of the young group (95%) and 179 of the non-young group (94%) ( Table 2 ). Young patients were more likely to have singlevessel disease and less likely to have culprit lesion in left circumflex coronary artery.
Results of Coronary Intervention
After emergency CAG, PCI were subsequently performed in 19 of the young group (91%) and 166 of the nonyoung group (87%) ( Table 3 ). The distribution of TIMI grade before and after primary PCI did not differ significantly between the 2 groups, nor did the acquisition rates of successful reperfusion or the rates of stent or aspiration usage. Maximum creatine kinase (CK) level in the young group was significantly higher than in the non-young group, but left ventricular ejection fraction (LVEF) and the length of hospital stay did not differ between the 2 groups.
Prognosis
The median follow-up time was 2.42 years for the young group and 2.37 years for the non-young group. The medium-term prognosis did not differ between the 2 groups ( Figs 1A,B) . The young group had a 95% survival rate at 3.75 years compared with a 92% survival rate in the nonyoung group (p=0.72). The young group had a 57% eventfree survival rate at 3.75 years compared with a 41% eventfree survival rate in the non-young group (p=0.49). There were no differences in the prevalence of any of the MACE between the 2 groups during the entire follow-up period (Table 4) , but the young patients with MACE had a high prevalence of multivessel disease (Table 5) and non-young patients with MACE had a high prevalence of multivessel disease, previous MI, and a significant longer length of hospital stay (Table 6) . A Cox proportional hazard model was developed to evaluate individual hazards of MACE and the predictor in the young group during the follow-up period was the presence of multivessel disease (hazard ratio (HR) 25.151; 95% confidence interval (CI) 2.636 to 239.977, p=0.0051), and in the non-young group the predictors were the presence of multivessel disease (HR 3.183; 95% CI 2.106 to 4.809, p<0.0001), previous MI (HR 2.449; 95% CI 1.582 to 3.789, p<0.0001) and the length of hospital stay (HR 1.009; 95% CI 1.001 to 1.016, p=0.024). LVEF was not a statistically significant predictor of MACE in either group.
Discussion
The major findings of the present multicenter study are that survival rate and event-free survival rate during medium-term follow-up in young AMI patients are comparable to those in non-young AMI patients in Japan; the predictor of MACE after hospital discharge was the presence of multivessel disease in the young patients, whereas for the non-young patients the predictors were the presence of multivessel disease, previous MI, and the longer length of hospital stay.
Based on our hypothesis that there is a difference in etiology of AMI between young and older patients, it is possible that either the clinical effectiveness of PCI or the medium-and long-term prognosis for young adults with AMI differs from that for older patients. In an attempt to exclude as far as possible the influence of increased age on medium-term outcome, we did not enrol patients aged ≥70 years old at the time of infarction in the non-young group. Moreover, in order to clearly elucidate the characteristics and prognosis of young AMI patients, we excluded patients aged 40-60 years who would be chronologically close to those aged <40 years.
A preponderance of males, high prevalence of smoking, and greater BMI in the young AMI patients were found in the present study, which is consistent with the results in previous reports. 1, 7, 11, 16, 17 Cigarette smoking is an established and modifiable major risk factor for coronary heart disease (CHD) in young patients as well as in older patients. On the other hand, obesity is a risk factor for CHD among adults 18 and is increasing in prevalence among young and older adults. 19, 20 A previous report has indicated a significant association of obesity with coronary atherosclerosis in young adult men, particularly in those with a central pattern of adiposity, and little association of obesity with coronary atherosclerosis in young adult women. 21 In addition, a recent report has shown that adiposity and its metabolic disturbances (metabolic syndrome) are associated with early atherosclerotic change in adolescents 22 and another recent report has also shown that metabolic syndrome-associated CHD prevalence in young men is approximately 2-fold that of a control group, whereas that in young women is almost the same as the controls. 23 There is a possibility that the frequent risk factors in the young group, such as smoking and obesity, did not play a critical role in the pathogenesis of AMI. In fact, a casecontrol study is a more suitable design than the comparison of young and elderly patients with AMI. However, it is difficult to collect control data for both healthy young adults and healthy non-young adults in Kyoto Prefecture. According to the 2004 JT smoking statistics, the rate of smoking among males is 52.2%, 56.35, and 32.65 in 20-30-yearolds, 30-40-year-olds, and 60-70-year-olds, respectively, compared with 5.8% in 60-70-year-old females. In our present report, the respective rates of smoking among the male AMI patients were 76.2% and 54.7% in the young and non-young groups, compared with 30.0% in 60-70-year-old female AMI patients. Thus, irrespective of age and gender, the prevalence of smoking in AMI patients might be higher than in healthy subjects.
As to obesity, based on the data from the 1998 Kyoto Citizen's Health and Nutrition Study, BMI of males aged 20-30 years, 30-40 years and 60-70 years was 21.5, 23.0, and 22.7, respectively, compared with 22.7 for 60-70-yearold females. 24, 25 In the present study, the BMI of the males in the young and non-young groups was 26.6 and 23.5, respectively, compared with 22.8 in 60-70-year-old females. Thus, the BMI in young male adult AMI patients is probably higher than that of healthy subjects, whereas in the non-young adults there might be no significant difference in BMI between AMI patients and healthy subjects, irrespective of gender. Taken together, we should not underestimate the significant role of smoking and obesity in the pathogenesis of AMI in young patients with a lower incidence of co-morbid disease such as diabetes mellitus and hypertension. These observations support the current emphasis on smoking cessation and control of obesity to prevent young adult CHD.
We have already demonstrated that primary PCI for young Japanese adults with AMI can be safe and effective in the short term. 13 Regarding facilitated PCI, a recent report has indicated that efficacy and safety do not differ between young and elderly patients with AMI. 26 As to the long-term outcome of PCI, previous studies have indicated that young patients with angina have a high need for repeat revascularization and many of them suffer another AMI in the follow-up period, 27 and that young patients with AMI have a low restenosis rate. 28 The present results suggests that the medium-term efficacy of primary PCI for young AMI patients is comparable to that in non-young AMI patients in Japan. However, the long-term efficacy of PCI for young Japanese adults with AMI is unknown and longterm follow-up is needed.
There were a few inconsistent data in the present report. First, the maximum CK level in the young group was significantly higher than that in the non-young group, but neither the prevalence of killip 3/4 nor the TIMI grade just after primary PCI differed between the 2 groups. Although we cannot explain the discrepancy precisely, we cannot rule out the possibility that prevalence of either pre-infarction angina or rich collateral circulation might be higher in the non-young group, compared with the young group. In addition, the maximum CK might not reflect the exact extent of infarction, because summation of CK is considered to be equivalent to a quantity of infarction. However, LVEF did not differ between the 2 groups. Second, nonyoung AMI patients with MACE had a significant longer length of hospital stay than non-young AMI patients without MACE. The prevalence of Killip 3/4 at admission in the non-young group was relatively higher than that in young group, but not significantly, and that in the nonyoung group with MACE was relatively higher than that in the non-young group without MACE, but not significantly. Moreover, the prevalence of previous MI in the non-young group was significantly higher than in the young group and that in the non-young group with MACE was significantly higher than in the non-young group without MACE. Therefore, besides PCI for non-culprit lesions in patients with multiple diseased vessels, congestive heart failure, which a complication of AMI, in hospital might contribute to the longer length of hospital stay in the non-young AMI patients.
In our recent report, there were no in-hospital deaths of young AMI patients, and in-hospital survival rates did not differ significantly between the young group (100%) and the non-young group (93%). 13 Previous analyses have indicated that the incidence of in-hospital complications, such as congestive heart failure, cardiogenic shock, and death, are lower in young AMI patients. 4, 7 As to the short-and longterm prognosis, most previous reports have shown a favorable outcome after discharge for young AMI patients. 1, 14, 15 It has been speculated that young patients have an improved survival rate compared with old patients because of less severe coronary artery involvement, 29, 30 but recent reports have demonstrated that the long-term prognosis of young AMI patients is not benign, especially when there is low ejection fraction, previous MI, previous bypass surgery, or peripheral atherosclerotic disease. 31, 32 However, there are no data on the medium-and long-term prognosis of young Japanese patients with AMI. In the present report, we have demonstrated for the first time that the medium-term prognosis in young AMI patients is comparable to that in nonyoung AMI patients in Japan, but the survival curves or event-free survival curves showed a slight, but not significant, difference approximately 2 years after discharge between the young and non-young groups. The follow-up period (average 2.4 years) may have been too short to detect significant difference in either survival rates or event-free survival rates. In addition, the event-free survival rates in both groups were smaller than those of Westerners in the previous studies. 32, 33 Although we cannot explain the discrepancy precisely, we cannot rule out the possibility that ad-hoc PCI subsequent to follow-up CAG is frequently performed irrespective of symptoms, because follow-up CAG tends to be routinely performed in Japan.
Study Limitations
First, this is a retrospective analysis of a small number of patients. Second, the present study population consisted of AMI patients who were admitted to collaborating hospitals in Kyoto Prefecture, therefore may not reflect the entire Japanese population. Third, follow-up data were not available for all patients. Further prospective studies or controlled case studies are needed to ascertain the pathogenesis and prognosis of AMI in young Japanese patients.
Conclusion
The present study provides evidence that the mediumterm prognosis in young AMI patients is comparable to that in non-young AMI patients in Japan. However, the longterm prognosis for young Japanese adults with AMI is uncertain and an extensive follow-up study is needed. In addition, the small sample size is a major limitation and a larger study should be performed to confirm our findings.
